title: Screening for cardiac risk before anthracycline administration: what are the real benefits?
authors: Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors: Michael S
authors: MS
authors: Ewer
authors: Ming
authors: M
authors: Yang
authors: Aman U
authors: AU
authors: Buzdar
mesh_terms: D018943:Anthracyclines / Q000008:administration & dosage* / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000175:diagnosis*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D005260:Female; D006333:Heart Failure / Q000139:chemically induced / Q000175:diagnosis / Q000517:prevention & control; D006801:Humans; D018570:Risk Assessment
chemical_list: D018943:Anthracyclines; D000970:Antineoplastic Agents